E-CELERATE, NCT05181540: A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation |
|
|
| Terminated | 3 | 130 | US | AB-205, E-CEL cells, Placebo | Angiocrine Bioscience, California Institute for Regenerative Medicine (CIRM) | Hodgkin Lymphoma, Non Hodgkin Lymphoma | 12/23 | 01/25 | | |
003SCD101, NCT03653247: A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease |
|
|
| Active, not recruiting | 1/2 | 8 | US | Plerixafor, Busulfan, BIVV003, Autologous CD34 + hematopoietic stem cells | Sangamo Therapeutics | Sickle Cell Disease | 07/25 | 07/25 | | |
